Sapphiros invests in growth-stage diagnostic companies, focusing on technologies that prioritize innovation and patient-centric approaches.
Sapphiros has raised $12.4M in total funding. The most recent round was Grant. The last funding was announced in July 2026.
Sapphiros's investors include Kohlberg Kravis Roberts & Co., National Institutes of Health, OraSure Technologies, Biomedical Advanced Research and Development Authority (BARDA).
Sapphiros is headquartered in Boston, United States.
Sapphiros invests in growth-stage diagnostic companies, focusing on technologies that prioritize innovation and patient-centric approaches.
Sapphiros is at the Grant stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Sapphiros — Funding & Investors." VCBacked, July 14, 2026, https://www.vcbacked.co/company/sapphiros. Accessed September 1, 2026.
VCBacked. (2026). Sapphiros — Funding & Investors. Retrieved September 1, 2026, from https://www.vcbacked.co/company/sapphiros
{{cite web |title=Sapphiros — Funding & Investors |url=https://www.vcbacked.co/company/sapphiros |website=VCBacked |access-date=September 1, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated